Dashboard
Manage Tickers

PFEPFIZER INC

NYSE pfizer.com


$ 29.70 $ -0.32 (-1.07 %)    

Thursday, 18-Jul-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 480.70 $ -2.28 (-0.47 %)
DIA $ 406.94 $ -5.21 (-1.26 %)
SPY $ 552.84 $ -4.28 (-0.77 %)
TLT $ 93.46 $ -0.72 (-0.76 %)
GLD $ 225.79 $ -1.45 (-0.64 %)
$ 29.71
$ 29.97
$ 0.00 x 0
$ 0.00 x 0
$ 29.64 - $ 30.69
$ 24.83 - $ 35.80
47,279,678
na
169.26B
$ 0.57
nm
TBD
na
na ($ 0.06)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-22-2024 12-31-2023 10-K
3 11-08-2023 10-01-2023 10-Q
4 08-09-2023 07-02-2023 10-Q
5 05-10-2023 04-02-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-09-2022 10-02-2022 10-Q
8 08-10-2022 07-03-2022 10-Q
9 05-11-2022 04-03-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-12-2021 10-03-2021 10-Q
12 08-12-2021 07-04-2021 10-Q
13 05-13-2021 04-04-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-05-2020 09-27-2020 10-Q
16 08-06-2020 06-28-2020 10-Q
17 05-07-2020 03-29-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 11-07-2019 09-29-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 02-28-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-09-2018 07-01-2018 10-Q
25 05-10-2018 04-01-2018 10-Q
26 02-22-2018 12-31-2017 10-K
27 11-09-2017 10-01-2017 10-Q
28 08-10-2017 07-02-2017 10-Q
29 05-11-2017 04-02-2017 10-Q
30 02-23-2017 12-31-2016 10-K
31 11-10-2016 10-02-2016 10-Q
32 08-11-2016 07-03-2016 10-Q
33 05-12-2016 04-03-2016 10-Q
34 02-29-2016 12-31-2015 10-K
35 11-05-2015 09-27-2015 10-Q
36 08-06-2015 06-28-2015 10-Q
37 05-07-2015 03-29-2015 10-Q
38 02-27-2015 12-31-2014 10-K
39 11-06-2014 09-28-2014 10-Q
40 08-07-2014 06-29-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

covid-activity-is-elevated-across-26-states-in-summer-surge-biden-remains-in-isolation-3-vaccine-stocks-to-watch
COVID Activity Is Elevated Across 26 State...
07/18/2024 19:59:25

Over half of US states have high levels of Covid-19 in wastewater as President Biden isolates with virus. New vaccines expected...

johnson--johnson-prioritizes-sustainable-growth-in-ma-amid-sector-diversification-says-analyst
Johnson & Johnson Prioritizes Sustainable ...
07/18/2024 18:51:35

Johnson & Johnson reports Q2 EPS of $2.82, up 10.2% YoY, beating expectations. Analysts foresee strong MedTech markets ahea...

vix-stages-double-digit-spike-as-risk-off-takes-over-chipmakers-fail-to-rebound-weight-loss-giants-eli-lilly-novo-tumble-whats-driving-markets-thursday
VIX Stages Double-Digit Spike As Risk Off ...
07/18/2024 18:05:28

It’s another risk-off day on Wall Street, with all major U.S. indices trading in the red. The CBOE Volatility Index (VIX), ofte...

pfizervalnevas-vaccine-study-for-tick-borne-infection-completes-primary-vaccination-series-plans-approval-in-2026
Pfizer/Valneva's Vaccine Study For Tick-Bo...
07/18/2024 18:05:07

Pfizer and Valneva announced the completion of the primary vaccination series in the Phase 3 VALOR trial for their Lyme disease...

Core News & Articles
President Biden's Doctor Says President Bi...
07/18/2024 17:44:15

- Reuters 

pfizer-stock-nears-golden-cross-signals-potential-upside-with-strong-oncology-portfolio
Pfizer Stock Nears Golden Cross, Signals P...
07/18/2024 15:40:56

Pfizer Inc (NYSE: PFE) is showing a bullish Golden Cross, indicating potential upward momentum for the stock.

pfizer-cisco-arch-capital-and-more-cnbcs-final-trades
Pfizer, Cisco, Arch Capital And More: CNBC...
07/18/2024 12:27:44

On CNBC's "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management said he is staying long on Pfi...

Core News & Articles
OPKO Health Enters Into $250M Non-Dilutive...
07/17/2024 20:15:37

Core News & Articles
Pfizer And Valneva Announce Primary Vaccin...
07/17/2024 20:02:27

Participants completed primary vaccination series (3 doses) with VLA15 Primary vaccination series to be followed by a booster a...

european-commission-faces-court-criticism-over-covid-vaccine-contract-transparency-ahead-of-vote-on-ursula-von-der-leyens-reappointment
European Commission Faces Court Criticism ...
07/17/2024 18:24:05

European Commission faces scrutiny over COVID vaccine contract transparency ahead of key vote. Legal challenges and implication...

Core News & Articles
CNBC Halftime Report Final Trades: Pfizer,...
07/17/2024 17:01:24

pfizer-and-roche-advance-on-their-weight-loss-drug-journeys
Pfizer And Roche Advance On Their Weight L...
07/17/2024 14:48:52

After previously discounting a twice-daily version of its weight loss drug due to patients having difficulties tolerating it, P...

Core News & Articles
CytoReason Secures $80M From OurCrowd, NVI...
07/17/2024 12:13:56

New funding will expand CytoReason's disease models and proprietary data, enabling R&D leaders at partner companies to ...

wall-streets-most-accurate-analysts-say-buy-these-3-health-care-stocks-with-over-3-dividend-yields
Wall Street's Most Accurate Analysts Say B...
07/15/2024 18:08:21

decoding-pfizers-options-activity-whats-the-big-picture
Decoding Pfizer's Options Activity: What's...
07/15/2024 17:01:29

viiv-healthcare-to-announce-data-from-randomised-clinical-trial-for-2-drug-regimen-dovato-against-3-drug-regimen-biktarvy-at-aids-2024
Viiv Healthcare To Announce Data From Rand...
07/15/2024 12:33:01

Findings from the SEIMC-GeSIDA Foundation (FSG) PASO-DOBLE study will include treatment efficacy, safety, and weight gain exper...

inflation-drop-fuels-rate-cut-speculation-investors-shift-to-sector-laggards-russell-2000-surges-over-36-this-week-in-the-markets
Inflation Drop Fuels Rate Cut Speculation,...
07/12/2024 20:33:07

Inflation drops, speculations rise on interest rate cuts. Producer inflation data fails to alter expectations, tech sector unde...

with-oral-anti-obesity-candidate-development-pfizer-seeks-relevant-and-competitive-presence---goldman-sachs
With Oral Anti-Obesity Candidate Developme...
07/12/2024 16:26:42

Pfizer has selected its preferred once-daily modified release formulation for danuglipron, an oral GLP-1 receptor agonist, with...

pfizer-l3harris-technologies-and-more-cnbcs-final-trades
Pfizer, L3Harris Technologies And More: CN...
07/12/2024 13:14:57

Pfizer selected Danuglipron, its once-daily weight loss drug, for continued advancement based on an ongoing pharmacokinetic study.

why-pfizer-stock-is-moving-higher-on-thursday
Why Pfizer Stock Is Moving Higher on Thursday
07/11/2024 17:34:58

Pfizer announced it will advance development of its once-daily Danuglipron.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)
07/23/2024 Fastly, Inc. (FSLY)
07/29/2024 Enphase Energy, Inc. (ENPH)
07/30/2024 Rivian Automotive, Inc. (RIVN)
07/30/2024 Hertz Global Holdings, Inc. (HTZ)
08/02/2024 Humana Inc. (HUM)
08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)